| Literature DB >> 35202167 |
Qingyi Liao1, Xiangjin Kong1, Guoqing Luo1, Xiangyue Wu1, Yinping Li1, Qicai Liu1, Cheng Tang1, Zhonghua Liu1.
Abstract
The venoms of toxic animals are chemical pools composed of various proteins, peptides, and small organic molecules used for predation and defense, in which the peptidic toxins have been intensively pursued mining modulators targeting disease-related ion channels and receptors as valuable drug pioneers. In the present study, we uncovered the molecular diversity of peptide toxins in the venom of the spider Heteropoda pingtungensis (H. pingtungensis) by using a combinatory strategy of venom gland cDNA library and transcriptome sequencing (RNA-seq). An amount of 991 high-quality expressed sequence tags (ESTs) were identified from 1138 generated sequences, which fall into three categories, such as the toxin-like ESTs (531, 53.58%), the cellular component ESTs (255, 25.73%), and the no-match ESTs (205, 20.69%), as determined by gene function annotations. Of them, 190 non-redundant toxin-like peptides were identified and can be artificially grouped into 13 families based on their sequence homology and cysteine frameworks (families A-M). The predicted mature toxins contain 2-10 cysteines, which are predicted to form intramolecular disulfide bonds to stabilize their three-dimensional structures. Bioinformatics analysis showed that toxins from H. pingtungensis venom have high sequences variability and the biological targets for most toxins are unpredictable due to lack of homology to toxins with known functions in the database. Furthermore, RP-HPLC and MALDI-TOF analyses have identified a total of 110 different peptides physically existing in the H. pingtungensis venom, and many RP-HPLC fractions showed potent inhibitory activity on the heterologously expressed NaV1.7 channel. Most importantly, two novel NaV1.7 peptide antagonists, µ-Sparatoxin-Hp1 and µ-Sparatoxin-Hp2, were characterized. In conclusion, the present study has added many new members to the spider toxin superfamily and built the foundation for identifying novel modulators targeting ion channels in the H. pingtungensis venom.Entities:
Keywords: Heteropoda pingtungensis; cDNA library; diversity; peptide toxin; transcriptome sequencing
Mesh:
Substances:
Year: 2022 PMID: 35202167 PMCID: PMC8876598 DOI: 10.3390/toxins14020140
Source DB: PubMed Journal: Toxins (Basel) ISSN: 2072-6651 Impact factor: 4.546
Figure 1H. pingtungensis venom gland ESTs annotations and distributions. (A) The spider H. pingtungensis. (B) Toxin-like ESTs derived from cDNA library and/or transcriptome sequencing. (C) Overlap of cellular component proteins identified in the cDNA library group with those proteins derived from transcriptome sequencing. (D) The relative proportion of each transcript category of H. pingtungensis venom gland ESTs.
Figure 2(A) EST, contig, unique gene, and protein distributions of toxin-like, cellular component, and non-matched ESTs among different cluster groups. (B) Toxins from H. pingtungensis were blasted against the toxins sequence library from H. venatoria, and the number of toxins showing different levels of homology (0–100% identity, in 10% increment) was counted, showing the toxin precursors from these two close spider species are basically different.
Figure 3Family analysis of toxin-like precursors in the venom gland of H. pingtungensis. The black-boxed regions indicate signal peptides and possible propeptides, and the red-boxed regions indicate the C-terminal amidation signals.
Figure 4Venom peptides diversity in H. pingtungensis and NaV1.7 inhibition activity of venom fractions. (A) RP-HPLC profile of H. pingtungensis venom. (B) MALDI-TOF analysis showing the molecular weight (MW) distribution and intensity of venom peptides in H. pingtungensis. (C) NaV1.7 inhibition activity of each RP-HPLC fraction in (A), the final testing concentration of venom peptides in each fraction is approximately 2–3 µM. Each dot represents a separate experimental cell, data are presented as MEAN ± SD. (D) Analytical RP-HPLC purification of the fraction HP-F-24 (left; star labeled peak indicates µ-Sparatoxin-Hp1), and reflectron mode (middle) and linear mode MALDI-TOF MS (right) analysis of µ-Sparatoxin-Hp1. Note the MW of 2442.8003 in reflectron mode MS analysis represents the toxin carrying two H+ [(M + 2H+)/2], and the small peak with MW of 3888.6421 might be a toxin fragment, as it is not presented in linear mode MS analysis. (E) Analytical RP-HPLC purification of the fraction HP-F-25 (left; star labeled peak indicates µ-Sparatoxin-Hp2) and linear mode MALDI-TOF MS (right) analysis of µ-Sparatoxin-Hp2. The toxin was not detected by reflectron mode MS analysis. (F) Representative traces showing the inhibition of 3 µM µ-Sparatoxin-Hp1 and µ-Sparatoxin-Hp2 on NaV1.7 currents (n = 5–6).